Recent advances in Schiff base coinage metal complexes as anticancer agents: A comprehensive review (2021–2025)
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Metal complexes synthesis and properties · Ferrocene Chemistry and Applications · Organometallic Compounds Synthesis and Characterization
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Global cancer statistics for adolescents and young adults: population based study10.1186/s13045-024-01623-9 ↗
2. Exploring treatment options in cancer: tumor treatment strategies
3. An explicative review on the current advancement in schiff base-metal complexes as anticancer agents evolved in the past decade: medicinal chemistry aspects
4. Lanthanides as anticancer agents10.2174/156801105774574694 ↗
5. Copper complexes as anticancer agents10.2174/187152009787313837 ↗
6. Recent advances and therapeutic journey of Schiff base complexes with selected metals (Pt, Pd, Ag, Au) as potent anticancer agents: a review10.2174/1871520622666220511125600 ↗
7. Platinum-based drugs: past, present and future10.1007/s00280-016-2976-z ↗
8. Advancements in platinum-based anticancer drug development: a comprehensive review of strategies, discoveries, and future perspectives10.1016/j.bmc.2024.117894 ↗
9. Bioactivity and development of small non-platinum metal-based chemotherapeutics
10. Drug transporters of platinum-based anticancer agents and their clinical significance10.1016/j.drup.2010.12.002 ↗
11. Overcoming the challenges of drug development in platinum-resistant ovarian cancer10.3389/fonc.2023.1258228 ↗
12. Metal complexes in cancer therapy – an update from drug design perspective10.2147/DDDT.S119488 ↗
13. Elevating the discourse on drug delivery: a fresh perspective on the utilization of coordination chemistry-driven metal-drug conjugates10.1016/j.ccr.2024.216026 ↗
14. Recent insights on the medicinal chemistry of metal-based compounds: hints for the successful drug design10.2174/092986710793213779 ↗
15. Metallodrugs are unique: opportunities and challenges of discovery and development10.1039/D0SC04082G ↗
16. Challenges and opportunities in the development of metal-based anticancer theranostic agents10.1042/BSR20212160 ↗
17. Recent advances and therapeutic journey of schiff base complexes with selected metals (Pt, Pd, Ag, Au) as potent anticancer agents: a review10.2174/1871520622666220511125600 ↗
18. Recent advances in anticancer ruthenium Schiff base complexes10.1002/aoc.5687 ↗
19. Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy10.1039/C7MD00526A ↗
20. In vitro anticancer activities of Schiff base and its lanthanum complex10.1016/j.saa.2015.10.015 ↗
21. DNA/BSA binding studies and in vitro anticancer and antibacterial studies of isoelectronic Cu(I)- and Ag(I)-pyridinyl Schiff base complexes incorporating triphenylphosphine as co-ligands10.1016/j.ica.2023.121760 ↗
22. Alteration of anticancer and protein-binding properties of gold(I) alkynyl by phenolic schiff bases moieties10.3390/pharmaceutics13040461 ↗
23. Investigating the cytotoxic, apoptotic, treatment-resistant, and inflammatory response properties of a gold(III) complex containing a tetradentate schiff base ligand
24. Iron (III) and zinc (II) monodentate Schiff base metal complexes: synthesis, characterisation and biological activities10.1016/j.molstruc.2021.129946 ↗
25. Biological and analytical applications of Schiff base metal complexes derived from salicylidene-4-aminoantipyrine and its derivatives: a review10.1007/s13738-021-02265-1 ↗
26. Multidentate unsymmetrically-substituted Schiff bases and their metal complexes: synthesis, functional materials properties, and applications to catalysis10.1016/j.ccr.2017.11.030 ↗
27. Metal complexes driven from Schiff bases and semicarbazones for biomedical and allied applications: a review
28. Schiff bases and their metal complexes as urease inhibitors – a brief review10.1016/j.jare.2018.03.007 ↗
29. Recent advances in schiff base ruthenium metal complexes: synthesis and applications
30. Synthesis, characterization and biological assay of Salicylaldehyde Schiff base Cu(II) complexes and their precursors10.1016/j.molstruc.2017.11.022 ↗
31. Silver(I)-pyridinyl Schiff base complexes: synthesis, characterisation and antimicrobial studies10.1016/j.molstruc.2017.01.061 ↗
32. Evaluation of a Schiff base copper complex compound as potent anticancer molecule with multiple targets of action10.1016/j.ejphar.2010.08.003 ↗
33. Structure and biological properties of mixed-ligand Cu(II) Schiff base complexes as potential anticancer agents10.1016/j.ejmech.2017.04.026 ↗
34. Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity10.1016/j.ejmech.2020.112234 ↗
35. Coordination behaviours of new (bidentate N,O-chelating) Schiff bases towards copper(II) and nickel(II) metal ions: synthesis, characterization, antimicrobial, antioxidant, and DFT studies10.1007/s11164-016-2841-z ↗
36. In vitro study of the pro-apoptotic mechanism of amino acid Schiff base copper complexes on anaplastic thyroid cancer10.1016/j.ejps.2025.107005 ↗
37. Emerging trends in metal-based anticancer agents: drug design to clinical trials and their mechanism of action10.1002/slct.202302113 ↗
38. Metal-based antitumour drugs in the post-genomic era: what comes next?10.1039/c1dt10522a ↗
39. A TBET based BODIPY-rhodamine dyad for the ratiometric detection of trivalent metal ions and its application in live cell imaging10.1016/j.snb.2016.06.131 ↗
40. Recent advances in platinum-based chemotherapeutics that exhibit inhibitory and targeted mechanisms of action10.1016/j.jinorgbio.2020.111070 ↗
41. Platinum compounds: a hope for future cancer chemotherapy10.2174/1871520611313020016 ↗
42. Platinum-based drugs for cancer therapy and anti-tumor strategies10.7150/thno.69424 ↗
43. Platinum-based drugs in cancer treatment: expanding horizons and overcoming resistance10.1016/j.molstruc.2023.137366 ↗
44. The rediscovery of platinum-based cancer therapy
45. Platinum-based combination therapy: molecular rationale, current clinical uses, and future perspectives10.1021/acs.jmedchem.0c00950 ↗
46. Highlights of new strategies to increase the efficacy of transition metal complexes for cancer treatments10.3390/molecules28010273 ↗
47. Research progress of metal anticancer drugs
48. Photoactive and luminescent transition metal complexes as anticancer agents: a guiding light in the search for new and improved cancer treatments10.3390/biomedicines10030578 ↗
49. Novel metals and metal complexes as platforms for cancer therapy10.2174/138161210791209009 ↗
50. Jia · Rev: recent adv. future develop. metal complexe. as anticancer agents · 2017 · 70 · 2175
51. Riding the metal wave: a review of the latest developments in metal-based anticancer agents10.1016/j.ccr.2023.215579 ↗
52. Redox-active metal complexes for anticancer therapy10.1002/ejic.201600908 ↗
53. Recent developments on other platinum metal complexes as target-specific anticancer therapeutics10.1016/j.ccr.2023.215231 ↗
54. A survey of the mechanisms of action of anticancer transition metal complexes10.4155/fmc-2016-0153 ↗
55. Metal complexes driven from Schiff bases and semicarbazones for biomedical and allied applications: a review
56. Structural characterization and biological activity of a new metal complexes based of Schiff base10.1016/j.molliq.2021.115522 ↗
57. An overview of Aniline-Based Schiff base metal Complexes: synthesis, characterization and biological activities - a review10.1016/j.inoche.2023.111851 ↗
58. Schiff bases and their metal complexes as potential anticancer candidates: a review of recent works10.2174/1871520619666190227171716 ↗
59. Schiff bases and complexes: a review on anti-cancer activity10.2174/1871520620666200507091207 ↗
60. Copper(II) Schiff base complexes: synthetic and medicinal perspective10.1016/j.inoche.2023.111409 ↗
61. Synthesis, spectral, antitumor and antimicrobial studies on Cu(II) complexes of purine and triazole Schiff base derivatives10.1016/j.molstruc.2013.06.059 ↗
62. Anti-cancer activity and mutagenic potential of novel copper(II) quinolinone Schiff base complexes in hepatocarcinoma cells10.1016/j.ejphar.2012.06.004 ↗
63. Advances in copper complexes as anticancer agents10.1021/cr400135x ↗
64. Anticancer effects of copper (II) hydrazone schiff base complex: a review
65. Anticancer activity and mechanism of action evaluation of an acylhydrazone Cu(II) complex toward breast cancer cells, spheroids, and mammospheres10.1002/cmdc.202100520 ↗
66. Aroylhydrazone Cu(Ⅱ) complexes: syntheses, crystal structures, and anticancer properties10.1016/j.molstruc.2021.130469 ↗
67. Synthesis and biological evaluation of six L-tryptophan Schiff base copper(II) complexes as promising anticancer agents in vitro10.1016/j.molstruc.2022.132578 ↗
68. Influence of anchoring moieties on new benzimidazole-based Schiff base copper(II) complexes towards estrogen dependent breast cancer cells10.1039/D0DT03873C ↗
69. Synthesis, characterization, crystal structure, DNA and HSA interactions, and anticancer activity of a mononuclear Cu(II) complex with a schiff base ligand containing a thiadiazoline moiety10.1021/acsomega.1c05750 ↗
70. Synthesis and antitumor activities of five Cu(II) complexes of bis(5-halosalicylidene)-1,3-propanediamine derivatives10.1093/mtomcs/mfac086 ↗
71. Shivaraj, Spectroscopic, quantum chemical calculations, antioxidant, anticancer, antimicrobial, DNA binding and photo physical properties of bioactive Cu(II) complexes obtained from trifluoromethoxy aniline Schiff bases10.1016/j.molstruc.2021.131601 ↗
72. Molecular docking, synthesis, anticancer activity, and computational investigations of thiazole-based ligands and their Cu(II) complexes10.1002/poc.4384 ↗
73. Antioxidant and anticancer potential of the new Cu(II) complexes bearing imine-phenolate ligands with pendant amine N-donor groups10.3390/pharmaceutics15020376 ↗
74. Copper(II) Schiff base complex derived from salen ligand: structural investigation, Hirshfeld surface analysis, anticancer and anti-SARS-CoV-2
75. Structure, interaction with biomolecules, and cytotoxicity of copper (II) complexes chelating some Schiff base ligands10.1002/aoc.7253 ↗
76. Biophysical study on DNA and BSA binding activity of Cu(II) complex: synthesis, molecular docking, cytotoxic activity, and theoretical approach10.1002/aoc.7164 ↗
77. O donor schiff base Cu(II) complex inhibits bacterial biofilm formation and promotes apoptosis and cell cycle arrest in prostate cancer cells10.1016/j.jinorgbio.2023.112314 ↗
78. New copper(II) complexes containing tryptophan based Schiff bases as promising antiproliferative agents on breast cancer cells10.1016/j.molstruc.2023.137273 ↗
79. New copper (II) complexes bearing tryptophan-based Schiff bases and 2,2′-bipyridine: crystal structures, DNA/BSA interactions and antiproliferative activities10.1002/aoc.7369 ↗
80. Novel copper (II) complexes with fluorine-containing reduced schiff base ligands showing marked cytotoxicity in the HepG2 cancer cell line10.3390/ijms25179166 ↗
81. Synthesis, characterization, and cytotoxic effects of new copper complexes using Schiff-base derivatives from natural sources10.1016/j.jinorgbio.2023.112401 ↗
82. Copper(II) complexes with N,O-donor azo-Schiff base ligands: synthesis, structure, DFT studies, molecular docking, anticancer and antimicrobial activity10.1016/j.poly.2025.117393 ↗
83. Theoretical insights and anticancer potential of 2,6-bis((E)-(2-amino-4-nitrophenylimino)methyl)-4-methoxyphenol and its binuclear Cu(II) complex10.1002/aoc.7984 ↗
84. Silver complexes as anticancer agents: a perspective review10.5530/gjpb.2022.1.3 ↗
85. Synthesis, theoretical investigations, biocidal screening, DNA binding, in vitro cytotoxicity and molecular docking of novel Cu (II), Pd (II) and Ag (I) complexes of chlorobenzylidene Schiff base: promising antibiotic and anticancer agents10.1002/aoc.4527 ↗
86. Synthesis , spectral characterization and anticancer studies of novel azo schiff base and its complexes with Ag(I),Au(lll) and Pt(lV) ions, Egypt
87. Synthesis, characterization and in vitro cytotoxic properties of new silver(I) complexes of two novel Schiff bases derived from thiazole and pyrazine10.1016/j.poly.2014.01.014 ↗
88. Non-linear optical property and biological assays of therapeutic potentials under in vitro conditions of Pd(II), Ag(I) and Cu(II) complexes of 5-diethyl amino-2-({2-[(2-hydroxy-Benzylidene)-amino]-phenylimino}-methyl)-phenol10.3390/molecules25215089 ↗
89. Evaluation of substituent bioactivity and anion impact of linear and T-shaped silver(I) pyridinyl complexes as potential antiproliferative, antioxidant, antimicrobial agents and DNA- and BSA-binders10.1039/D1NJ03231C ↗
90. Silver(I) pyridinyl complexes with benzothiazole, thiophene, and furan moieties: DNA/protein-binding, antibacterial, antioxidant, and anticancer studies10.1002/ardp.202200308 ↗
91. Quinoline functionalized schiff base silver (I) complexes: interactions with biomolecules and in vitro cytotoxicity, antioxidant and antimicrobial activities10.3390/molecules26051205 ↗
92. Mononuclear discrete Ag(I) complexes of aryl substituted (E)-N-phenyl-1-(pyridin-3-yl)methanimine: in vitro biological activities and interactions with biomolecules, South African
93. Synthesis and characterization of schiff bases and their Ag(I) complexes containing 2,5,6-trisubstituted imidazothiadiazole derivatives: molecular docking and in vitro cytotoxic effects against nonsmall lung cancer cell line10.1002/jbt.70142 ↗
94. A new Ag(I) complex based on asymmetric azine-type ligand as a promising anticancer agent: synthesis, X-ray structure, and DFT calculations10.1016/j.molstruc.2024.140908 ↗
95. M. Bian, X. Wang, Y. Sun, W.L.-E. journal of medicinal chemistry, undefined 2020, Synthesis and biological evaluation of gold (III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity, Elsevier. (n.d.). https://www.sciencedirect.com/science/article/pii/S0223523420302014 (accessed March 13, 2021).10.1016/j.ejmech.2020.112234 ↗
96. Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases10.1039/D1CS00933H ↗
97. Gold complexes in anticancer therapy: from new design principles to particle-based delivery systems10.1002/anie.202218000 ↗
98. Synthesis of nano-metric gold complexes with new schiff bases derived from 4-aminoantipyrene, their structures and anticancer activity10.1134/S1070363217120519 ↗
99. Gold(III) complex from pyrimidine and morpholine analogue Schiff base ligand: synthesis, characterization, DFT, TDDFT, catalytic, anticancer, molecular modeling with DNA and BSA and DNA binding studies10.1016/j.molliq.2019.111655 ↗
100. Triphenylphosphine thiolate gold(I) complexes with redox-active schiff bases: synthesis, electrochemical properties, and biological activity10.1134/S1070328423600420 ↗